Philippe Gambert Selected Research

Philippe Gambert Research Topics

Disease

7	Atherosclerosis 07/2013 - 08/2002
6	Myocardial Infarction 09/2012 - 09/2005
4	Inflammation (Inflammations) 07/2013 - 11/2009
4	Insulin Resistance 10/2011 - 10/2002
4	Neoplasms (Cancer) 07/2011 - 10/2003
4	Colonic Neoplasms (Colon Cancer) 07/2011 - 10/2003
4	Chronic Hepatitis C 12/2007 - 05/2003
3	Abdominal Obesity 12/2007 - 10/2002
2	Type 2 Diabetes Mellitus (MODY) 06/2009 - 06/2006
2	Carcinoma (Carcinomatosis) 02/2008 - 11/2004
2	Fatty Liver 12/2007 - 06/2006
2	Fibrosis (Cirrhosis) 07/2007 - 05/2003
2	Atherosclerotic Plaque (Atheroma) 05/2006 - 04/2003
2	Hypertriglyceridemia 11/2005 - 10/2002
2	Infections 04/2005 - 05/2003
1	Hyperplasia 01/2013
1	Hypertrophy 01/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2011
1	Leukemia 07/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2011
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 03/2011
1	Rupture 08/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2008
1	Respiratory Insufficiency (Respiratory Failure) 01/2008
1	Critical Illness (Critically Ill) 01/2008
1	Persistent Infection 07/2007
1	Heart Failure 02/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2007
1	Hyperhomocysteinemia 01/2007
1	Homocysteinemia 01/2007
1	Obesity 06/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2006
1	Hyperlipidemias (Hyperlipidemia) 05/2006
1	Splenomegaly 11/2005
1	Thrombocytopenia (Thrombopenia) 11/2005
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2005
1	Hypertension (High Blood Pressure) 09/2005
1	Necrosis 09/2005
1	Cardiogenic Shock 09/2005
1	Hypoadiponectinemia 04/2005
1	Overweight 04/2005

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 06/2013 - 04/2003
6	OxysterolsIBA 07/2013 - 08/2002
4	CholesterolIBA 07/2013 - 02/2008
4	Triglycerides (Triacylglycerol)IBA 12/2007 - 10/2002
4	7-ketocholesterolIBA 06/2005 - 08/2002
3	Liver X ReceptorsIBA 07/2013 - 01/2012
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2013 - 01/2012
3	ResveratrolIBA 07/2011 - 10/2003
3	oxidized low density lipoproteinIBA 08/2009 - 10/2002
3	Lipoproteins (Lipoprotein)IBA 12/2007 - 10/2002
3	ApolipoproteinsIBA 06/2006 - 05/2003
3	Death Domain ReceptorsIBA 11/2004 - 10/2003
2	Proteins (Proteins, Gene)FDA Link 03/2011 - 05/2010
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2009 - 06/2006
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 05/2008 - 01/2007
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2008 - 09/2005
2	pro-brain natriuretic peptide (1-76)IBA 01/2008 - 02/2007
2	Cholesterol Ester Transfer ProteinsIBA 11/2007 - 05/2003
2	HDL CholesterolIBA 06/2007 - 11/2005
2	IsotopesIBA 06/2006 - 10/2002
2	AdiponectinIBA 06/2006 - 04/2005
2	Insulin (Novolin)FDA Link 10/2005 - 10/2002
2	LigandsIBA 11/2004 - 05/2004
2	PolyphenolsIBA 11/2004 - 10/2003
2	CaspasesIBA 11/2004 - 10/2003
2	Apolipoproteins B (ApoB)IBA 05/2003 - 10/2002
2	LDL Lipoproteins (beta Lipoproteins)IBA 05/2003 - 10/2002
2	cholest-5-en-3 beta,7 alpha-diolIBA 04/2003 - 08/2002
1	Pravastatin (Pravachol)FDA LinkGeneric 09/2012
1	adiponutrinIBA 10/2011
1	ClathrinIBA 07/2011
1	Monensin (Coban)IBA 07/2011
1	Antineoplastic Agents (Antineoplastics)IBA 07/2011
1	Subfamily D ATP Binding Cassette TransporterIBA 03/2011
1	Adenosine Triphosphate (ATP)IBA 03/2011
1	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 03/2011
1	KinesinsIBA 05/2010
1	Caveolin 1IBA 08/2009
1	Rosuvastatin Calcium (Crestor)FDA Link 06/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2009
1	LDL CholesterolIBA 06/2009
1	CeramidesIBA 02/2008
1	LeptinIBA 12/2007
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 12/2007
1	HDL LipoproteinsIBA 11/2007
1	Cholesterol Esters (Cholesteryl Esters)IBA 11/2007
1	LDL Receptors (LDL Receptor)IBA 07/2007
1	Indicators and Reagents (Reagents)IBA 01/2007
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2007
1	microsomal triglyceride transfer proteinIBA 06/2006
1	C-Reactive ProteinIBA 05/2006
1	CytokinesIBA 05/2006
1	Apolipoproteins E (ApoE)IBA 11/2005
1	CreatinineIBA 09/2005
1	TroponinIBA 09/2005
1	ThiazolidinedionesIBA 04/2005
1	AdipokinesIBA 04/2005

Therapy/Procedure

4	Therapeutics 10/2005 - 05/2003
1	Secondary Prevention 09/2012